MDLZ Stock Analysis: Mondelez International | NASDAQ

Confectioners | NASDAQ, USA | Market Cap: 80.908m USD | 12M Return: 5.5% | US6092071058 | Charts, Fundamentals & Technical Analysis

Biscuits, Chocolates, Confectionery, Snacks
Total Rating 57
Safety 71
Buy Signal 0.21
Confectioners
Industry Rotation: +7.8
Market Cap: 80.9B
Avg Turnover: 460M
Risk 3d forecast
Volatility24.6%
VaR 5th Pctl4.29%
VaR vs Median5.87%
Reward TTM
Sharpe Ratio0.17
Rel. Str. IBD64.7
Rel. Str. Peer Group80.7 pctl
Character TTM
Beta-0.268
Beta Downside-0.172
Hurst Exponent0.467
Choppyness70.8%
Drawdowns 3y
Max DD29.00%
CAGR/Max DD0.08
CAGR/Mean DD0.18
EPS (Earnings per Share) EPS (Earnings per Share) of MDLZ over the last years for every Quarter: "2021-09": 0.71, "2021-12": 0.71, "2022-03": 0.84, "2022-06": 0.67, "2022-09": 0.74, "2022-12": 0.73, "2023-03": 0.89, "2023-06": 0.76, "2023-09": 0.82, "2023-12": 0.84, "2024-03": 0.95, "2024-06": 0.86, "2024-09": 0.99, "2024-12": 0.65, "2025-03": 0.74, "2025-06": 0.73, "2025-09": 0.73, "2025-12": 0.72, "2026-03": 0.67, "2026-06": 0.73,
EPS CAGR: -6.94%
EPS Trend: -75.3%
Last SUE: 1.36
Qual. Beats: 2
Revenue Revenue of MDLZ over the last years for every Quarter: 2021-09: 7182, 2021-12: 7658, 2022-03: 7764, 2022-06: 7274, 2022-09: 7763, 2022-12: 8695, 2023-03: 9166, 2023-06: 8507, 2023-09: 9029, 2023-12: 9314, 2024-03: 9290, 2024-06: 8343, 2024-09: 9204, 2024-12: 9604, 2025-03: 9313, 2025-06: 8984, 2025-09: 9744, 2025-12: 10496, 2026-03: 10080, 2026-06: 9355,
Rev. CAGR: 3.99%
Rev. Trend: 94.0%
Last SUE: 1.00
Qual. Beats: 3

Warnings

No concerns identified

Tailwinds

Idiosyncratic Leader

Seasonality 11.7 years of data

Jan +0.4% 8
Feb -2.3% 17
Mar -2.6% 9
Apr +2.8% 55
May -0.3% 22
Jun -0.2% 7
Jul +1.9% 21
Aug -1.8% 24
Sep -1.5% 16
Oct -3.0% 15
Nov +1.5% 14
Dec +0.4% 13

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: MDLZ Mondelez International

Mondelez International, Inc. (NASDAQ: MDLZ) is a global manufacturer, marketer, and seller of snack food and beverage products, operating across Latin America, North America, Asia, the Middle East, Africa, and Europe. Its portfolio spans biscuits and baked snacks (including cookies, crackers, salted snacks, snack bars, and cakes and pastries), chocolates, gums and candies, and a range of cheese, grocery, and powdered beverage products. Well-known brands in the lineup include Oreo, Ritz, LU, CLIF Bar, Tates Bake Shop, Cadbury Dairy Milk, Milka, and Toblerone.

The company distributes through supermarket chains, wholesalers, supercenters, club stores, mass merchandisers, convenience stores, drug stores, and other retail food outlets, using a mix of direct store delivery, company-owned and satellite warehouses, distribution centers, and third-party distributors. It also sells directly to businesses and consumers via e-retail platforms, retailer digital platforms, its own direct-to-consumer websites, and social media. As a large-cap consumer staples name in the packaged foods sub-industry, MDLZ relies on a globally diversified brand portfolio and extensive multi-channel distribution to drive relatively stable, repeat-purchase revenues typical of defensive food categories.

Mondelez International was formerly known as Kraft Foods Inc., adopting its current name in October 2012 after being incorporated in 2000. The company is headquartered in Chicago, Illinois, and has been listed on NASDAQ since its IPO on June 13, 2001.

Headlines to Watch Out For
  • Emerging market FX headwinds pressure reported revenue and earnings
  • Cocoa and commodity input costs compress gross margins
  • Pricing power on Oreo and Cadbury offsets snack volume softness
Piotroski VR-10 (Strict) 6.0
Net Income: 3.52b TTM > 0 and > 6% of Revenue
FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.30 > 1.0
NWC/Revenue: -21.81% < 20% (prev -19.22%; Δ -2.59% < -1%)
CFO/TA 0.06 > 3% & CFO 4.44b > Net Income 3.52b
Net Debt (20.9b) to EBITDA (6.26b): 3.34 < 3
Current Ratio: 0.60 > 1.5 & < 3
Outstanding Shares: last quarter (1.29b) vs 12m ago -0.54% < -2%
Gross Margin: 31.15% > 18% (prev 32.55%; Δ -1.40% > 0.5%)
Asset Turnover: 55.78% > 50% (prev 52.25%; Δ 3.53% > 0%)
Interest Coverage Ratio: 8.30 > 6 (EBIT TTM 4.88b / Interest Expense TTM 587.0m)
Altman Z'' 2.00
A: -0.12 (Total Current Assets 12.9b - Total Current Liabilities 21.6b) / Total Assets 71.2b
B: 0.52 (Retained Earnings 37.2b / Total Assets 71.2b)
C: 0.07 (EBIT TTM 4.88b / Avg Total Assets 71.1b)
D: 0.60 (Book Value of Equity 26.6b / Total Liabilities 44.6b)
Altman-Z'' = 2.00 = BBB
Beneish M -2.93
DSRI: 1.01 (Receivables 5.01b/4.63b, Revenue 39.7b/37.1b)
GMI: 1.05 (GM 32.55% / 31.15%)
AQI: 0.99 (AQ_t 0.66 / AQ_t-1 0.66)
SGI: 1.07 (Revenue 39.7b / 37.1b)
TATA: -0.01 (NI 3.52b - CFO 4.44b) / TA 71.2b)
Beneish M = -2.93 (Cap -4..+1) = A
What is the price of MDLZ shares?

As of October 21, 2026, the stock is trading at USD 63.99 with a total of 5,996,297 shares traded. Over the past week, the price has changed by +4.05%, over one month by +7.29%, over three months by +7.11% and over the past year by +5.50%.

Current recommended Stop Loss: 61.80 (which is 3.4% or 1.8 ATR below the current price).

Is MDLZ a buy, sell or hold?

Mondelez International has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy MDLZ.

  • StrongBuy: 11
  • Buy: 4
  • Hold: 8
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the MDLZ price?
Analysts Target Price 69 7.8%
Mondelez International (MDLZ) - Fundamental Data Overview as of 17 October 2026
Market Cap USD = 80.9b (80.9b USD * 1.0 USD.USD)
P/E Trailing = 23.1728
P/E Forward = 18.1818
P/S = 2.0276
P/B = 2.9264
P/EG = 0.9044
Revenue TTM = 39.7b USD
EBIT TTM = 4.88b USD
EBITDA TTM = 6.26b USD
Long Term Debt = 17.2b USD (from longTermDebt, last fiscal year)
Short Term Debt = 4.99b USD (from shortTermDebt, last quarter)
Debt = 22.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 598.0m
Net Debt = 20.9b USD (calculated: Debt 22.7b - CCE 1.72b)
Enterprise Value = 102b USD (80.9b + Debt 22.7b - CCE 1.72b)
Interest Coverage Ratio = 8.30 (Ebit TTM 4.88b / Interest Expense TTM 587.0m)
EV/FCF = 33.01x (Enterprise Value 102b / FCF TTM 3.08b)
FCF Yield = 3.03% (FCF TTM 3.08b / Enterprise Value 102b)
FCF Margin = 7.78% (FCF TTM 3.08b / Revenue TTM 39.7b)
Net Margin = 8.86% (Net Income TTM 3.52b / Revenue TTM 39.7b)
Gross Margin = 31.15% ((Revenue TTM 39.7b - Cost of Revenue TTM 27.3b) / Revenue TTM)
Gross Margin QoQ = 42.61% (prev 27.81%)
Tobins Q-Ratio = 1.43 (Enterprise Value 102b / Total Assets 71.2b)
Interest Expense / Debt = 2.59% (Interest Expense 587.0m / Debt 22.7b)
Taxrate = 23.09% (990.0m / 4.29b)
NOPAT = 3.75b (EBIT 4.88b * (1 - 23.09%))
Current Ratio = 0.60 (Total Current Assets 12.9b / Total Current Liabilities 21.6b)
Debt / Equity = 0.85 (Debt 22.7b / totalStockholderEquity, last quarter 26.6b)
Debt / EBITDA = 3.34 (Net Debt 20.9b / EBITDA 6.26b)
Debt / FCF = 6.79 (Net Debt 20.9b / FCF TTM 3.08b)
Total Stockholder Equity = 26.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.94% (Net Income 3.52b / Total Assets 71.2b)
RoE = 13.47% (Net Income TTM 3.52b / Total Stockholder Equity 26.1b)
RoCE = 11.25% (EBIT 4.88b / Capital Employed (Equity 26.1b + L.T.Debt 17.2b))
RoIC = 7.08% (NOPAT 3.75b / Invested Capital 52.9b)
WACC = 4.15% (E(80.9b)/V(104b) * Re(4.75%) + D(22.7b)/V(104b) * Rd(2.59%) * (1-Tc(0.23)))
Discount Rate = 4.75% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.62 | Cagr: -2.09%
[DCF] Terminal Value 76.41% ; FCFF base≈3.00b ; Y1≈3.20b ; Y5≈3.85b
[DCF] Fair Price = 29.70 (EV 59.1b - Net Debt 20.9b = Equity 38.1b / Shares 1.28b; r=8.35% [WACC [floored]]; 5y FCF grow 7.83% → 2.50% )
EPS Correlation: -75.26 | EPS CAGR: -6.94% | SUE: 1.36 | # QB: 2
Revenue Correlation: 93.98 | Revenue CAGR: 3.99% | SUE: 1.00 | # QB: 3
EPS current Quarter (2026-09-30): EPS=0.71 | Chg30d=-0.36% | Revisions=-50% | Analysts=17
EPS current Year (2026-12-31): EPS=3.05 | Chg30d=+0.04% | Revisions=+12% | GrowthEPS=+4.4% | GrowthRev=+4.1%
EPS next Year (2027-12-31): EPS=3.37 | Chg30d=+0.10% | Revisions=-12% | GrowthEPS=+10.3% | GrowthRev=+2.8%
[Analyst] Revisions Ratio: -9% (up=14, down=17)